Communiqués de Truffle et de ses participations

SYMETIS

EU Launch For Acurate Transfemoral TAVI System - Medical industry Week

Pdf

SYMETIS

Symetis a obtenu l'homologation de certification CE pour son système d'implantation de valve aortique transcathter ACURATE neo(TM) et lance son produit pour des premières implantations commerciales - BioMedReports

Pdf

SYMETIS

12th September 2014 - Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Pdf

SYMETIS

28th October 2013 - Symetis Announces a Symbolic Milestone: the 1000th Patient implanted with ACURATE TA™

Pdf

SYMETIS

26th September 2013 - Symetis and Endoluminal Sciences enter into a license agreement to develop 3rd generation TAVI

Pdf

SYMETIS

Symetis' Accurate TA 30-day follow-up data shows encouraging results - Medical Industry Week

Pdf

SYMETIS

Symetis' Accurate TA confirms superior results

Pdf

Truffle Capital

5 Rue de la Baume 75008 Paris France
Tel: +33 1 82 28 46 00
Email: contact@truffle.com

© 2018 Truffle Capital

Truffle Capital 2018

Réseaux Sociaux

 
eb4d938a464d491a4dc7556efc515567JJJJJJJJJJJJJJJJJJJJJJ